Cochlear implant provider awareness of vaccination guidelines

Anita Jeyakumar, Rodolpho E. Bégué, Yu Jiang, Brian McKinnon

Research output: Contribution to journalArticle

Abstract

Objective: Guidelines for vaccination of cochlear implant (CI) recipients have been promulgated and updated by the Center for Disease Control and Prevention (CDC) to mitigate bacterial meningitis risk. The objective of this study was to survey current CI specialists on: 1) knowledge of current CDC CI recipient immunization recommendations, and 2) impediments to implementation of those guidelines. Methods: A survey to assess knowledge of the CI recipient vaccination guidelines was administered to the American Academy of Otolaryngology–Head and Neck surgery (AAO–HNS), the American Cochlear Implant Alliance (ACIA), and the American Neurotology Society (ANS). The members of the AAO–HNS and ACIA were invited to participate in the survey via an e-mail. The members of the ANS were polled during a session of their fall meeting. Results: A total of 256 individuals participated: 64 from AAO, 59 from ACIA, and 133 from ANS. Participants reported knowledge of the vaccination guidelines as high among all groups and statistically similar. The survey indicated that the participants noted difficulty in obtaining age-group–specific immunizations. Vaccination status was not consistently reported. Conclusion: Cochlear implant providers have high awareness of vaccination guidelines but less detailed knowledge of age-specific recommendations. Obtaining age-specific vaccines is a challenge, as is consistent documentation of vaccination. Future efforts should be focused on improving knowledge of age-specific recommendations, easing access of age-specific vaccines, and improving documentation. Level of Evidence: NA. Laryngoscope, 128:2145–2152, 2018.

Original languageEnglish (US)
Pages (from-to)2145-2152
Number of pages8
JournalLaryngoscope
Volume128
Issue number9
DOIs
StatePublished - Sep 1 2018
Externally publishedYes

Fingerprint

Immunization Programs
Cochlear Implants
Guidelines
Neurotology
Vaccination
Centers for Disease Control and Prevention (U.S.)
Documentation
Immunization
Neck
Vaccines
Laryngoscopes
Bacterial Meningitides
Postal Service
Surveys and Questionnaires

Keywords

  • Cochlear implant
  • meningitis
  • vaccination

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Cochlear implant provider awareness of vaccination guidelines. / Jeyakumar, Anita; Bégué, Rodolpho E.; Jiang, Yu; McKinnon, Brian.

In: Laryngoscope, Vol. 128, No. 9, 01.09.2018, p. 2145-2152.

Research output: Contribution to journalArticle

Jeyakumar, Anita ; Bégué, Rodolpho E. ; Jiang, Yu ; McKinnon, Brian. / Cochlear implant provider awareness of vaccination guidelines. In: Laryngoscope. 2018 ; Vol. 128, No. 9. pp. 2145-2152.
@article{f3d7a9ac232b435a82cf396863cb7aef,
title = "Cochlear implant provider awareness of vaccination guidelines",
abstract = "Objective: Guidelines for vaccination of cochlear implant (CI) recipients have been promulgated and updated by the Center for Disease Control and Prevention (CDC) to mitigate bacterial meningitis risk. The objective of this study was to survey current CI specialists on: 1) knowledge of current CDC CI recipient immunization recommendations, and 2) impediments to implementation of those guidelines. Methods: A survey to assess knowledge of the CI recipient vaccination guidelines was administered to the American Academy of Otolaryngology–Head and Neck surgery (AAO–HNS), the American Cochlear Implant Alliance (ACIA), and the American Neurotology Society (ANS). The members of the AAO–HNS and ACIA were invited to participate in the survey via an e-mail. The members of the ANS were polled during a session of their fall meeting. Results: A total of 256 individuals participated: 64 from AAO, 59 from ACIA, and 133 from ANS. Participants reported knowledge of the vaccination guidelines as high among all groups and statistically similar. The survey indicated that the participants noted difficulty in obtaining age-group–specific immunizations. Vaccination status was not consistently reported. Conclusion: Cochlear implant providers have high awareness of vaccination guidelines but less detailed knowledge of age-specific recommendations. Obtaining age-specific vaccines is a challenge, as is consistent documentation of vaccination. Future efforts should be focused on improving knowledge of age-specific recommendations, easing access of age-specific vaccines, and improving documentation. Level of Evidence: NA. Laryngoscope, 128:2145–2152, 2018.",
keywords = "Cochlear implant, meningitis, vaccination",
author = "Anita Jeyakumar and B{\'e}gu{\'e}, {Rodolpho E.} and Yu Jiang and Brian McKinnon",
year = "2018",
month = "9",
day = "1",
doi = "10.1002/lary.27117",
language = "English (US)",
volume = "128",
pages = "2145--2152",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "9",

}

TY - JOUR

T1 - Cochlear implant provider awareness of vaccination guidelines

AU - Jeyakumar, Anita

AU - Bégué, Rodolpho E.

AU - Jiang, Yu

AU - McKinnon, Brian

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Objective: Guidelines for vaccination of cochlear implant (CI) recipients have been promulgated and updated by the Center for Disease Control and Prevention (CDC) to mitigate bacterial meningitis risk. The objective of this study was to survey current CI specialists on: 1) knowledge of current CDC CI recipient immunization recommendations, and 2) impediments to implementation of those guidelines. Methods: A survey to assess knowledge of the CI recipient vaccination guidelines was administered to the American Academy of Otolaryngology–Head and Neck surgery (AAO–HNS), the American Cochlear Implant Alliance (ACIA), and the American Neurotology Society (ANS). The members of the AAO–HNS and ACIA were invited to participate in the survey via an e-mail. The members of the ANS were polled during a session of their fall meeting. Results: A total of 256 individuals participated: 64 from AAO, 59 from ACIA, and 133 from ANS. Participants reported knowledge of the vaccination guidelines as high among all groups and statistically similar. The survey indicated that the participants noted difficulty in obtaining age-group–specific immunizations. Vaccination status was not consistently reported. Conclusion: Cochlear implant providers have high awareness of vaccination guidelines but less detailed knowledge of age-specific recommendations. Obtaining age-specific vaccines is a challenge, as is consistent documentation of vaccination. Future efforts should be focused on improving knowledge of age-specific recommendations, easing access of age-specific vaccines, and improving documentation. Level of Evidence: NA. Laryngoscope, 128:2145–2152, 2018.

AB - Objective: Guidelines for vaccination of cochlear implant (CI) recipients have been promulgated and updated by the Center for Disease Control and Prevention (CDC) to mitigate bacterial meningitis risk. The objective of this study was to survey current CI specialists on: 1) knowledge of current CDC CI recipient immunization recommendations, and 2) impediments to implementation of those guidelines. Methods: A survey to assess knowledge of the CI recipient vaccination guidelines was administered to the American Academy of Otolaryngology–Head and Neck surgery (AAO–HNS), the American Cochlear Implant Alliance (ACIA), and the American Neurotology Society (ANS). The members of the AAO–HNS and ACIA were invited to participate in the survey via an e-mail. The members of the ANS were polled during a session of their fall meeting. Results: A total of 256 individuals participated: 64 from AAO, 59 from ACIA, and 133 from ANS. Participants reported knowledge of the vaccination guidelines as high among all groups and statistically similar. The survey indicated that the participants noted difficulty in obtaining age-group–specific immunizations. Vaccination status was not consistently reported. Conclusion: Cochlear implant providers have high awareness of vaccination guidelines but less detailed knowledge of age-specific recommendations. Obtaining age-specific vaccines is a challenge, as is consistent documentation of vaccination. Future efforts should be focused on improving knowledge of age-specific recommendations, easing access of age-specific vaccines, and improving documentation. Level of Evidence: NA. Laryngoscope, 128:2145–2152, 2018.

KW - Cochlear implant

KW - meningitis

KW - vaccination

UR - http://www.scopus.com/inward/record.url?scp=85054408209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054408209&partnerID=8YFLogxK

U2 - 10.1002/lary.27117

DO - 10.1002/lary.27117

M3 - Article

VL - 128

SP - 2145

EP - 2152

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 9

ER -